Why is the presence of autoantibodies against GAD associated with a relatively slow progression to clinical diabetes?

Anette Gabriele Ziegler; Ezio Bonifacio

doi:10.1007/s00125-020-05175-8

Why is the presence of autoantibodies against GAD associated with a relatively slow progression to clinical diabetes?

Anette Gabriele Ziegler, Ezio Bonifacio

Department of Pediatric Medicine

Research output: Contribution to journal › Letter › peer-review

13 Scopus citations

Original language	English
Pages (from-to)	1665-1666
Number of pages	2
Journal	Diabetologia
Volume	63
Issue number	8
DOIs	https://doi.org/10.1007/s00125-020-05175-8
State	Published - 1 Aug 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00125-020-05175-8

Cite this

@article{5d0af9d6c6a34701964a6d62a5c96681,

title = "Why is the presence of autoantibodies against GAD associated with a relatively slow progression to clinical diabetes?",

author = "Ziegler, {Anette Gabriele} and Ezio Bonifacio",

year = "2020",

month = aug,

day = "1",

doi = "10.1007/s00125-020-05175-8",

language = "English",

volume = "63",

pages = "1665--1666",

journal = "Diabetologia",

issn = "0012-186X",